Stocks
Arrowhead Pharmaceuticals, Inc.ARWR
NASDAQHealthcareBiotechnology$55.05+0.07%
Specializing in RNA interference (RNAi) therapeutics, this biotech firm develops treatments for intractable diseases through gene silencing technology. With multiple candidates in clinical trials, including treatments for cardiovascular and liver diseases, the company attracts investor attention for its potential in addressing high unmet medical needs.
Market Cap: $7.7B52W Range: $9.57 – $76.76
Congressional Interest in Arrowhead Pharmaceuticals, Inc. (ARWR)
1 member of Congress has disclosed 1 trade in Arrowhead Pharmaceuticals, Inc. (ARWR), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ARWR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-31 | Daniel Goldman | sell | $1K – $15K |